| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $21.6M | +154.5% |
| Cost of Revenue | $17.6M | +140.3% |
| Gross Profit | $4.0M | +244.0% |
| R&D Expense | $19K | +1800.0% |
| SG&A Expense | $7.5M | +74.7% |
| Operating Income | -$3.7M | -15.2% |
| Pre-tax Income | -$4.2M | -21.7% |
| Income Tax | $1K | +0.0% |
| Net Income | -$4.2M | -21.7% |
| EPS (Basic) | -$0.80 | +18.4% |
| EPS (Diluted) | -$0.80 | +18.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.2M | +2044.3% |
| Accounts Receivable | $2.4M | -45.9% |
| Inventory | $1.0M | -37.5% |
| Current Assets | $10.3M | +54.9% |
| Total Assets | $11.9M | +54.6% |
| Current Liabilities | $6.2M | -32.2% |
| Long-term Debt | $2.0M | -26.8% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.7M | -47.6% |
| Investing Cash Flow | $250K | +0.0% |
| Financing Cash Flow | $11.6M | +223.5% |
| $7.5M |
| -38.6% |
| Stockholders' Equity | $4.4M | +197.4% |